category
PNAS
date
Mar 17, 2026
slug
status
Published
summary
开发了一种基于合成SIGLEC9的嵌合开关受体,通过改造CAR巨噬细胞的信号传导机制,显著提升其对抗胶质母细胞瘤的治疗效果。
tags
合成生物学
type
Post
📄 原文题目
Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma
🔗 原文链接
💡 AI 核心解读
开发了一种基于合成SIGLEC9的嵌合开关受体,通过改造CAR巨噬细胞的信号传导机制,显著提升其对抗胶质母细胞瘤的治疗效果。
📝 英文原版摘要
Proceedings of the National Academy of Sciences, Volume 123, Issue 12, March 2026. <br />SignificanceGlioblastoma multiforme (GBM) is a lethal brain tumor for which current immunotherapies provide little durable benefit. Tumor-associated macrophages (TAMs) are abundant in GBM but are driven toward an immune-suppressive state by ...
- 作者:NotionNext
- 链接:https://tangly1024.com/article/32e48bd6-1f96-8167-bcad-ca37cbd673d0
- 声明:本文采用 CC BY-NC-SA 4.0 许可协议,转载请注明出处。
相关文章
